These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8623727)

  • 1. Indinavir approved for HIV infection.
    Am Fam Physician; 1996 May; 53(6):2203. PubMed ID: 8623727
    [No Abstract]   [Full Text] [Related]  

  • 2. Indinavir (Crixivan), Merck protease inhibitor, approved.
    James JS
    AIDS Treat News; 1996 Mar; (no 243):1-2. PubMed ID: 11363299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
    Schouten JT
    STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA notifications. Alternative dosing regimen for atazanavir is approved.
    AIDS Alert; 2008 Nov; 23(11):129-30. PubMed ID: 19048649
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approval: tipranavir.
    Sax PE
    AIDS Clin Care; 2005 Aug; 17(8):78. PubMed ID: 16193574
    [No Abstract]   [Full Text] [Related]  

  • 6. Two more HIV protease inhibitors approved.
    Fox JL
    Nat Biotechnol; 1996 Apr; 14(4):427. PubMed ID: 9669874
    [No Abstract]   [Full Text] [Related]  

  • 7. Glaxo, Merck and ADAP.
    GMHC Treat Issues; 1996 May; 10(5):8. PubMed ID: 11363584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA approves nelfinavir. Food and Drug Administration.
    GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA notifications. Revised atazanavir package insert.
    AIDS Alert; 2008 Mar; 23(3):35-6. PubMed ID: 18661642
    [No Abstract]   [Full Text] [Related]  

  • 10. 3TC and protease inhibitors: citizen's petition asks faster approval.
    AIDS Treat News; 1995 Apr; (no 220):5. PubMed ID: 11362321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indinavir (Crixivan).
    Treat Rev; 1996 Apr; (no 21):7. PubMed ID: 11363398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viramune cleared for use in combination with protease inhibitors.
    AIDS Patient Care STDS; 1998 Nov; 12(11):872. PubMed ID: 11362046
    [No Abstract]   [Full Text] [Related]  

  • 13. Kaletra OK'd by FDA.
    James JS
    Posit Living; 2000 Nov; 9(9):8, 13. PubMed ID: 12154764
    [No Abstract]   [Full Text] [Related]  

  • 14. Getting your space on the magic crixi-van.
    Gilden D
    GMHC Treat Issues; 1996 Mar; 10(3):4. PubMed ID: 11363390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two new protease inhibitors approved by FDA. Food and Drug Administration.
    Folkers G
    NIAID AIDS Agenda; 1996 Mar; ():4-5. PubMed ID: 11363799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drugs--reports of new drugs recently approved by the FDA. Indinavir.
    Bioorg Med Chem; 1997 Mar; 5(3):463-4. PubMed ID: 9113322
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV drug now approved for use with protease inhibitors.
    Nurse Pract; 1998 Oct; 23(10):89. PubMed ID: 9805335
    [No Abstract]   [Full Text] [Related]  

  • 18. New protease inhibitor atazanavir (Reyataz) approved.
    AIDS Treat News; 2003 Jun; (392):3. PubMed ID: 12913956
    [No Abstract]   [Full Text] [Related]  

  • 19. Reyataz dosing options discussed. Excerpts from the FDA atazanavir hearing.
    Huff B
    GMHC Treat Issues; 2003 Jun; 17(6):8-11. PubMed ID: 12913962
    [No Abstract]   [Full Text] [Related]  

  • 20. Fourth protease inhibitor hits the market.
    AIDS Alert; 1997 May; 12(5):59-60. PubMed ID: 11364224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.